Published in Vaccine Weekly, March 8th, 2006
The clinical trial, sponsored by the National Institute of Allergy and Infectious Disease (NIAID), a component of the National Institutes of Health (NIH), is being conducted at the Cincinnati Children's Hospital Medical Center.
The phase I/II study is an inpatient dose-escalating clinical trial aimed at determining the safety and immunogenicity of the single-dose, oral Ty800 vaccine. The trial will evaluate three escalating dose levels of the vaccine, in approximately 54 healthy adult...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly